Collaboration with patient organizations

Genomic Medicine Sweden is striving to improve diagnostics, treatment and follow-up of a variety of diseases. We are also conducting research and collaborating with other stakeholders, with the purpose of improving the care and treatment of patients.

The network against cancer and Riksförbundet Sällsynta diagnosers logos

Knowledge about patients’ needs and experiences are a focal point in the development and implementation of broad gene analysis for improved diagnostics, treatment and follow-up in healthcare. In our management team there are two representatives from the patient organizations Rare Diseases Sweden and Network Against Cancer.

As the Genomic Medicine Sweden initiative continues to develop, more patient organizations will be involved in the work.

Introduction collaboration

GMS is a national initiative in genomic and precision medicine where collaboration plays a key role. Together with healthcare providers, academia, the private sector and patient organizations we create a unique foundation for strengthening Swedish healthcare, research, innovation and life-science in precision medicine.